Top High Dividend Stocks in July 2025 and Their Market Landscape

Highlights

• Key dividend selections span energy, consumer goods, real estate, and pharmaceuticals, offering diversified income sources.
• Focused on companies with strong dividend safety scores and business sustainability.
• Yield percentages remain competitive amid steady interest rate conditions and market valuations.

Dividend-oriented equities remain a critical component of income-generating strategies within Canada’s financial ecosystem. With macroeconomic factors stabilizing—particularly in interest rates—several high-yielding equities across key sectors continue to attract market attention. Notably, the companies listed span the energy infrastructure, real estate, consumer goods, utilities, and pharmaceutical industries. Relevant indexes such as the S&P/TSX Composite Index and the S&P/TSX Capped Utilities Index provide context to the performance and market relevance of these equities. The following selections are among the highlighted high dividend stocks for July 2025, evaluated using yield sustainability, business resilience, and valuation metrics.

Enterprise Products Partners L.P.

Enterprise Products Partners L.P. (TSX:EPD) ranks among North America's major midstream energy entities. Operating an expansive network of pipelines, processing units, and storage systems, the company plays a vital role in connecting upstream production with downstream demand. Its organizational structure as a master limited partnership provides taxation efficiencies while emphasizing infrastructure-based revenue streams.

Trading near $31.09 per share and carrying a market cap of approximately $67.50 billion, Enterprise Products focuses on fee-based income rather than commodity price fluctuations. This revenue model cushions its financials against energy market volatility. With a dividend safety score of 4.2 and a dividend yield of 6.88%, EPD demonstrates long-term consistency in cash distributions, maintaining payouts for over 25 years.

Choice Properties Real Estate Investment Trust

Choice Properties REIT (TSE:CHP.UN) is one of Canada's leading real estate trusts, with diversified holdings across retail, industrial, and mixed-use properties. Backed by long-term lease agreements and a tenant base anchored by Loblaw Companies Limited, the REIT benefits from relatively predictable cash flow streams.

As of mid-2025, CHP.UN trades around $14.85 per unit, with a market capitalization above $10 billion. The REIT holds a dividend safety score above 3.5, reflecting secure and steady distributions supported by income-generating assets. With a dividend yield near 5.8%, Choice Properties continues to attract attention within the broader real estate segment of the S&P/TSX Capped REIT Index.

North West Company Inc.

North West Company Inc. (TSX:NWC) operates a network of grocery and general merchandise stores, serving remote communities across northern Canada, Alaska, and the Caribbean. Its business model emphasizes stable consumer demand and logistical specialization in underserved regions.

Trading around $35.20, North West Company has a market capitalization of approximately $1.7 billion. The firm maintains a dividend yield of 4.4% with a dividend safety score near 3.9. Despite operating in a niche retail segment, the company’s consistent profitability and disciplined capital management support dependable shareholder distributions.

Emera Incorporated

Emera Incorporated (TSX:EMA) is a prominent electric utility with regulated operations across Canada, the United States, and the Caribbean. Its portfolio includes electricity generation, transmission, and natural gas distribution assets. As a defensive sector participant, the company benefits from relatively stable earnings visibility.

Emera’s stock trades close to $52.40 with a market cap exceeding $14 billion. The company offers a dividend yield of 5.5% and holds a dividend safety score of approximately 3.6. With its focus on regulated utilities and renewable energy investments, EMA aligns well with market trends favoring sustainable and reliable dividend payouts.

Pfizer Inc.

Pfizer Inc. (TSX:PFE) is a multinational pharmaceutical firm with a well-established portfolio of vaccines, therapeutics, and specialty drugs. Though primarily known for its global operations, the stock is dual-listed and included in several Canadian-focused equity portfolios due to its market capitalization and yield profile.

Pfizer trades near $27.10 with a market capitalization exceeding $150 billion. The company offers a dividend yield around 4.9% and maintains a dividend safety score over 3.0. Though pharmaceutical revenues can fluctuate due to patent cycles and regulatory dynamics, Pfizer’s broad pipeline and recurring healthcare demand contribute to sustained shareholder returns.

Sectoral Diversification and Yield Reliability

The selection spans diverse sectors, reducing concentration risk and enhancing income stability. Each of the above companies meets stringent dividend safety criteria, using consistent cash flows, prudent capital allocation, and conservative payout ratios. The strategic presence in core segments such as energy transmission, retail essentials, and healthcare ensures earnings support for dividend continuity.

Moreover, market conditions marked by steady interest rates and selective equity revaluations create favorable conditions for income-focused equity picks. Companies operating on fee-based or regulated models—such as TSX:EPD and TSX:EMA—present lower earnings volatility, further improving dividend consistency.

Yield Metrics and Valuation Observations

Most selected companies exhibit yields ranging from 4.4% to 6.88%, considerably above average S&P/TSX Composite Index levels. Current pricing relative to earnings and historical valuations suggest moderate pricing, with several trading near or below their 12-month historical averages.

Stocks like TSX:NWC and TSX:CHP.UN also reflect defensive characteristics, particularly relevant during economic slowdowns or interest rate shifts. Pharmaceutical exposure via TSX:PFE contributes to healthcare allocation, with enduring demand and innovation pipelines supporting payout sustainability.